Details for New Drug Application (NDA): 216947
✉ Email this page to a colleague
NDA 216947 describes ERTUGLIFLOZIN, which is a drug marketed by Aurobindo Pharma Ltd and Hetero Labs Ltd V and is included in two NDAs. Additional details are available on the ERTUGLIFLOZIN profile page.
The generic ingredient in ERTUGLIFLOZIN is ertugliflozin. Two suppliers are listed for this compound. Additional details are available on the ertugliflozin profile page.
The generic ingredient in ERTUGLIFLOZIN is ertugliflozin. Two suppliers are listed for this compound. Additional details are available on the ertugliflozin profile page.
Summary for 216947
| Tradename: | ERTUGLIFLOZIN |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | ertugliflozin |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Jul 13, 2023 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
| Approval Date: | Jul 13, 2023 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
